AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features sixteen therapeutic and diagnostic programs, including five in Phase 2 development and one in Phase 3. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.
Company Details
- Employees
- 178
- Founded
- -
- Address
- Epfl Innovation Park Building B, Lausanne,vaud 1015,switzerland
- Phone
- +41 21 345 91 21
- in****@****une.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.acimmune.com
- Keywords
- Therapeutics, Alzheimer's disease, Neuro-orphan diseases, Parkinson's disease, Diagnostics, Neurodegenerative diseases, Down syndrome, Misfolded proteins.
- HQ
- Lausanne, Vaud
Ac Immune Questions
Ac Immune's helpline number is +41 21 345 91 21
Ac Immune's website is http://www.acimmune.com
Ac Immune's LinkedIn profile is https://ch.linkedin.com/company/ac-immune
Ac Immune has
178 employees.
View email and phone details for 178
employees at Ac Immune.
Ac Immune's industry is
Biotechnology Research
Ac Immune's top competitors are
Ypsomed Ag,
Sophia Genetics,
Debiopharm,
Sobi - Swedish Orphan Biovitrum Ab (Publ),
Takeda,
Idorsia Pharmaceuticals Ltd,
Adc Therapeutics,
Biogen,
Celonic Group,
Siegfried.
Ac Immune's support email address is info@acimmune.com
Ac Immune's categories are Biotechnology Research
Ac Immune's founding year is 2003
